The impact of chronic TNFα on γδ T cells was reversible, suggesting that therapeutic strategies targeting the inflammatory environment and γδ T cell dysfunction may provide additional treatments for complications associated with obesity, metabolic disease and type 2 diabetes. Here, TNF is linked to type 2 diabetes mellitus.